Industry News

Though Intellectual Property (IP) disputes are not uncommon in the pharmaceutical industry, the scale and prominence of this litigation are of rare magnitude.

The Dennemeyer Group enters a new era.

A decades-long saga about the POLO brand and what it means to consumers in South Africa saw its most recent play.

The Dennemeyer Group is honored to be cited once again in the latest release of the World Trademark Review (WTR) 1000.

Facebook's rebrand as Meta serves as an effective illustration of how complex the process can be and the Intellectual Property implications it may hold.

On October 29, the UK government launched an open consultation to debate how the country’s existing IP legislation should be adapted to address the ongoing development of AIs and their use in the inventive process.

Pakistan is now the 108th member of the Madrid System, to the advantage of South Asia's IP sector and the wider economy.

As we saw with the trade war, conflicts between the U.S. and China can quickly escalate and have ripple effects throughout the world.

Now that the Japanese and French patent systems are aligned, applicants from both countries might be interested in taking advantage of this new PPH agreement.

A brief guide on all notable changes that IP rights holders have to face after the transition period ends on January 1, 2021.

Knock-off products are always a problem for business owners holding IP rights, but supply chain disruptions allow malevolent actors to make a tidy profit.

The year 2020 commenced in much the same way as most years do, but it quickly became apparent that the world needed to brace for the unexpected.